Literature DB >> 21506903

Skin tolerability of transdermal patches.

Johannes Wohlrab1, B Kreft, B Tamke.   

Abstract

INTRODUCTION: Transdermal patch systems are an effective method of administering active ingredients through the skin, with considerable advantages over other drug delivery routes, for example, maintenance of constant plasma drug levels and avoidance of first-pass metabolism. However, repeated epicutaneous application may be associated with local skin reactions. AREAS COVERED: This review addresses current issues regarding the effective/safe use of transdermal patch systems, and provides a critical analysis of the addition of 'skin-caring' ingredients to patch systems. Effective use of transdermal systems includes choosing an appropriate body area for application, maintaining regular skin care regimens before application and not replacing a patch in the same area (rotation) within 7 days. Another strategy, developed in an attempt to improve the tolerability of transdermal systems, is the addition of assumed 'skin-caring' ingredients (e.g., Aloe Vera) to patch systems. However, at present there is neither proof nor clinical evidence of any benefit. On the contrary, plant-derived ingredients might be associated with allergenic potential. EXPERT OPINION: Transdermal systems are generally well tolerated; physicians must adequately inform patients of the most effective ways to use these formulations for maximum therapeutic benefit, while minimising local adverse events. Skin-caring agents, including Aloe Vera, cannot be recommended until well-controlled clinical trials with standardised extracts are available.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506903     DOI: 10.1517/17425247.2011.574689

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  4 in total

Review 1.  An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine.

Authors:  Rita Khoury; Jayashree Rajamanickam; George T Grossberg
Journal:  Ther Adv Drug Saf       Date:  2018-01-08

2.  The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.

Authors:  Karim Hemati; Poupak Rahim Zadeh
Journal:  J Clin Diagn Res       Date:  2015-06-01

3.  Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system.

Authors:  Henrik Lövborg; Mikael Holmlund; Staffan Hägg
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-09       Impact factor: 2.483

Review 4.  Proniosomes derived niosomes: recent advancements in drug delivery and targeting.

Authors:  Maryam Khatoon; Kifayat Ullah Shah; Fakhar Ud Din; Shefaat Ullah Shah; Asim Ur Rehman; Naz Dilawar; Ahmad Nawaz Khan
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.